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Abstract
Objectives Lung-RADS represents a categorical system published by the American College of Radiology to standardise manage-
ment in lung cancer screening. The purpose of the studywas to quantify howwell readers agree in assigning Lung-RADS categories
to screening CTs; secondary goals were to assess causes of disagreement and evaluate its impact on patient management.
Methods For the observer study, 80 baseline and 80 follow-up scans were randomly selected from the NLST trial covering all
Lung-RADS categories in an equal distribution. Agreement of seven observers was analysed using Cohen’s kappa statistics.
Discrepancies were correlated with patient management, test performance and diagnosis of malignancy within the scan year.
Results Pairwise interobserver agreement was substantial (mean kappa 0.67, 95% CI 0.58–0.77). Lung-RADS category dis-
agreement was seen in approximately one-third (29%, 971) of 3360 reading pairs, resulting in different patient management in
8% (278/3360). Out of the 91 reading pairs that referred to scans with a tumour diagnosis within 1 year, discrepancies in only two
would have resulted in a substantial management change.
Conclusions Assignment of lung cancer screening CT scans to Lung-RADS categories achieves substantial interobserver agree-
ment. Impact of disagreement on categorisation of malignant nodules was low.
Key Points
• Lung-RADS categorisation of low-dose lung screening CTs achieved substantial interobserver agreement.
• Major cause for disagreement was assigning a different nodule as risk-dominant.
• Disagreement led to a different follow-up time in 8% of reading pairs.
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Introduction
The National Lung Screening Trial (NLST) demonstrated a
decrease in lung cancer-specific mortality of 20% [1].
Together with follow-up research, this led to a recommendation
of CT lung screening for eligible subjects by several organisa-
tions, including the US Preventative Services Task Force [2].
Lung cancer screening programs are now being implemented in
the USA. Interpretation of CTscans for lung cancer screening is
a labour-intensive task for radiologists and the assessment of
malignancy risk in pulmonary nodules remains challenging.
Various categorical management protocols and scoring systems
have been developed to aid radiologists in the selection of high-
risk nodules demanding a more invasive management [3–7].
Protocols are based on a combination of nodule type, nodule
size, nodule growth, and other additional parameters such as
subject characteristics and nodule morphology.
In 2014, the American College of Radiology (ACR) pub-
lished the Lung-RADS Assessment Categories to standardise
the CT lung screening reporting and management recommen-
dations and facilitate outcome monitoring [4]. Lung-RADS
contains five categories to differentiate high-risk from low-
risk nodules using nodule type, nodule size and growth as
criteria. For nodule type, solid is differentiated from subsolid
nodule composition with the latter having a relatively higher
malignancy risk [8]. Nodule size is determined using manual
diameter measurements and growth is defined as an increase of
at least 1.5mm in diameter. The primary criteria for the various
Lung-RADS categories are described in Table 1. A negative
screening result corresponds to category 1 (negative) or 2 (be-
nign appearance), while a positive screening corresponds to
category 3 (probably benign) or 4 (suspicious). The last cate-
gory is further divided into category 4A and 4B based on the
probability of malignancy (5–15% or greater than 15%).
Category 4X is a special category for lesions that demonstrate
additional features or imaging findings that increase the suspi-
cion of malignancy [4]. It is well known that both visual as-
sessment of nodule type and manual diameter measurements
suffer from substantial observer variability [9–13]. It is there-
fore of importance to evaluate how well radiologists agree on
such a categorical system that uses manual size measurements
and visual nodule classification as two major input parameters.
The purpose of this study was to quantify the interobserver
variability for applying the Lung-RADSAssessment Categories
to subjects having undergone low-dose screening computed to-
mography (CT). Secondary outcome parameters were the ef-
fects of interobserver variability on patient management and test
performance.
Materials and methods
Data
All study cases were derived from the NLST [14]. The NLST
was approved by the institutional review board of all participat-
ing centres and all participants provided informed consent. This
study has been registered by the NLSTstudy board under num-
ber NLST-187.
Assessment of Lung-RADS categories and study
group
The NLST included 26,309 subjects that underwent at least
one low-dose chest CT scan [14]. We received all scans
(screening rounds T0, T1 and T2) from a random sample of
Table 1 Lung-RADS assessment category criteria
Lung-RADS
category
Criteria for baseline CT scans Criteria for follow-up CT scans Management
1 No nodules, or nodules with complete, central,
popcorn or concentric rings of calcification,
fat-containing nodules
No nodules, or nodules with complete, central,
popcorn or concentric rings of calcification,
fat-containing nodules
Annual LDCT screening
2 SN < 6 mm
PSN < 6 mm in total diameter
GGN < 20 mm
SN and PSN < 6 mm
SN new < 4 mm
GGN < 20 mm or unchanged or slowly growing
Category 3–4 nodules unchanged at ≥ 3 months
Annual LDCT screening
3 SN ≥ 6 and <8 mm
PSN ≥ 6 mm in total diameter with solid
component < 6 mm
GGN ≥ 20 mm
SN new ≥ 4 and < 6 mm
PSN new < 6 mm
GGN new ≥ 20 mm
6 month LDCT
4A SN ≥ 8 and < 15 mm
PSN ≥ 6 mm with solid component ≥ 6 and
< 8 mm
SN growing < 8 mm or new ≥ 6 and < 8 mm
PSN ≥ 6 mm with new or growing solid
component < 4 mm
3 month LDCT; PET/CT
4B SN ≥ 15 mm
PSN with a solid component ≥8 mm
SN new or growing and ≥ 8 mm
PSN 6 mm with new or growing solid component
≥ 4 mm
Chest CTwith/without
contrast, PET/CTand/or
tissue sampling
SN solid nodule, PSN part-solid nodule, GGN pure ground-glass nodule
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4512 subjects. The NLST database provides information re-
garding nodule type, total nodule size and lobe location.
Information regarding lung cancer diagnosis is available for
all participants over a median follow-up period of 6.5 years. In
total, 6121 nodule annotations were recorded in the database
for these 4512 subjects.
Lung-RADS categorisation of all scans in this data set was
performed to be used as selection criteria later in this study.
Lung-RADS categories were assigned to all 6121 nodule an-
notations in the 4512 subjects using the pre-existing annota-
tions from the NLST database with respect to nodule type
(solid/part-solid/non-solid) and size (average of long and per-
pendicular diameter on axial section). This was done by a
researcher (Ph.D. candidate with anM.Sc. degree inmedicine)
and a chest radiologist with more than 20 years of experience.
Since category 4X is based on subjective morphological
criteria other than nodule type, size and growth, this category
was disregarded in our study. The nodule with the highest
Lung-RADS category determined the Lung-RADS category
for the CT scan. For Lung-RADS categorisation of the sub-
solid nodules listed in the NLST database, a medical student
specifically trained in segmentation and classification of pul-
monary nodules in screening CT scans semi-automatically
determined the size of the solid component because this infor-
mation is not provided by NLST. Note that this pre-study
Lung-RADS categorisation is only used to select cases but
did not serve as standard of truth.
To ensure a balanced representation of all Lung-RADS cat-
egories, we formed an enriched study group. Using the Lung-
RADS categories described above, we randomly selected 20
scans per category 1/2, 3, 4A and 4B, respectively, out of the
pool of 4512 participants. This was done separately for T0 and
T1 scans. Lung-RADS categories 1 and 2 were grouped to-
gether. Thus, our final data set for the observer study consisted
of 80 T0 scans, and 80 T1 CTscans with the corresponding 80
T0 scans from a total of 160 unique subjects.
Observers and reading methodology
Three radiologists and four fifth-year radiology residents from
five different medical centres participated in this study as ob-
servers. They had experience with pulmonary nodules and
reading chest CT scans ranging from 4 to 30 years. One of
them had experience with reading screening CTs.
A dedicated workstation was used (CIRRUS Lung
Screening, Radboud University Medical Center, Nijmegen,
the Netherlands) which allowed for evaluating the complete
CT scan in all three projections with interactive viewing tools
such as magnification, manual diameter measurements and
adjustment of window settings. Tools such as computer-
aided detection (CAD) marks, volumetry or automatic linking
of T0 and T1 scans were specifically disabled to mimic read-
ing in a PACS environment without dedicated computerised
applications. Nodule annotations made by readers were stored
by the workstation in a local database. Readers were not in-
formed about the selection or distribution of Lung-RADS cat-
egories within the study group.
For the baseline scans, observers were asked to assess the
complete CT scan, to define the risk-dominant nodule, select
the nodule type (solid, part-solid, pure ground-glass or calci-
fied) and measure the longest and perpendicular diameters on
axial sections, which were subsequently averaged and round-
ed to the nearest whole number [4]. Then they were asked to
categorise the CT scan into either Lung-RADS category 1, 2,
3, 4A or 4B on the basis of the risk-dominant nodule. Readers
were not asked to annotate all nodules; it was left to the
readers’ discretion to annotate and measure only a single
or—if it was felt necessary—several nodules in order to iden-
tify the risk-dominant nodule.
For the follow-up cases, the T0 and T1CTscans were shown
next to each other on two separate monitors allowing the two
scans to be reviewed side-by-side. T0 scans of the follow-up
cases had been pre-read by the researcher and an expert radiol-
ogist both not involved in the observer study. Their annotations
and Lung-RADS categories were available to the observers
while they were asked to categorise the follow-up scans.
All observers read all cases in different random order in at
least two reading sessions with unlimited reading time avail-
able. A printout with Lung-RADS categories was available
during the reading. Prior to the first reading session, each
reader individually studied a set of 24 training cases including
multiple cases per Lung-RADS category to get familiar with
Lung-RADS categorisation. For each case, the pre-existing
NLST annotations and the Lung-RADS category calculated
from them were available to the reader for feedback.
Analysis of reading data
Since the NLST did not assign CT scans to a Lung-RADS
category, there was no reference standard. For every case, it
was verified if observers had assigned the correct Lung-
RADS category to their own annotations; if not, such Lung-
RADS assignment errors were documented and subsequently
corrected by the researcher on the basis of the observer’s own
nodule annotations. Linearly weighted Cohen’s kappa statis-
tics was utilised to determine pairwise interobserver agree-
ment for the Lung-RADS categorisation of each CT scan.
Pairwise kappa values were averaged over all possible ob-
server pairs resulting in a mean kappa with a 95% confidence
interval (CI). Kappa values were interpreted using the Landis
and Koch guidelines [15]. Descriptive statistics were used
where appropriate. Discrepant readings were subdivided into
two groups dependent on whether the same or different nod-
ules were assigned as being risk-dominant. Only same-nodule
discrepancies were analysed and assessed for variation in the
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assignment of nodule type, assessment of growth or categor-
ical difference in absolute diameter measurement.
To quantify the impact of reader variability on the actual
test performance we assessed the observer variability for
assigning baseline (T0) scans into screening-negative (Lung-
RADS categories 1/2) or screening-positive scans (Lung-
RADS categories 3, 4A or 4B) similar to Pinsky et al. [16]
and McKee et al. [17].
Secondly, to assess the impact of observer disagreement on
actual subject management, a distinction was made between
minor and substantial management disagreement. A substan-
tial management discrepancy referred to a difference in
follow-up time of at least 9 months and occurred for disagree-
ment between Lung-RADS categories 1/2 and 4A or 4B, re-
spectively. Minor management discrepancies referred to a dif-
ference in follow-up of 6 months at maximum and occurred
for disagreement between Lung-RADS categories 1/2 and 3,
between categories 3 and 4A or 4B, respectively, or between
categories 4A and 4B, respectively. Numbers and percentages
are reported.
Results
In 6% of all scores (68/1120), observers assigned the wrong
Lung-RADS category to their own annotations. Those assign-
ment errors were revised on the basis of the reader’s personal
annotations of nodule type, size and growth. For the seven
observers, it occurred on average in 8.5 cases with a range
between 3 and 19.
Interobserver agreement
Interobserver agreement for the Lung-RADS categories was
substantial with a mean weighted kappa of 0.67 (95% CI
0.58–0.77) averaged over all observers. Weighted kappa
values varied from 0.63 (95% CI 0.53–0.73) to 0.73 (95%
CI 0.64–0.81) for the observer pairs, all being substantial.
Interobserver agreement was slightly higher for baseline
scans with a mean pairwise kappa of 0.70 (95% CI 0.58–
0.82), compared to 0.63 (95% CI 0.49–0.77) for the follow-
up scans.
Causes of Lung-RADS disagreement
When considering all possible reading pairs among the seven
observers (21 pairs × 160 scans = 3360 observations), dis-
agreement with respect to CT categorisation was observed in
about one-third (971/3360, 29%) and resulting in substantial
management difference in 8% of all reading pairs (278/3360).
Reading discrepancies were divided into those related to
the same risk-dominant nodule and into those related to dif-
ferent risk-dominant nodules.
Discrepancies related to the same risk-dominant nodule
turned out to be the minority with 26% (250/971, 47 cases),
in which the two observers assigned different Lung-RADS
categories on the basis of differences in nodule size measure-
ments (207/971, 21%), nodule type classification (37/971,
4%) or growth assessment (6/971, 1%). This led to substantial
discrepancies with respect to case management in only one
case (Lung-RADS 1/2 versus 4A). This specific case is shown
in Fig. 1.
The majority of pairwise disagreements (721/971, 74%),
however, were caused by assigning different nodules as risk-
dominant. Substantial management discrepancy between cat-
egories 1/2 and 4A or 4B occurred in 38% (277/721) of them
and occurred in 48 of the 160 subjects. In the majority of those
cases (77%, 553/721) the readers annotated only one nodule,
namely the risk-dominant one of his/her choice. In the minor-
ity of cases (23%, 168/721) observers annotated two nodules
but assigned a different risk stratification as a result of varia-
tions in nodule type classification (47/168, 28%), diameter
measurement or growth assessment (121/168, 72%).
Details are provided in Table 2. Figure 2 show examples of
cases where observers disagreed for various reasons.
Impact of nodule size on Lung-RADS disagreement
No correlation was seen between nodule size and reader
disagreement. In 94 of the 160 study subjects at least one
discrepant reading pair was seen. Only low-risk and thus
smaller nodules (categories 1/2 or 3) were recorded in 29
subjects, and only higher-risk and thus larger nodules (cat-
egories 3, 4A and/or 4B) were recorded in 17 subjects. In
the remaining 48 subjects a mix of low- and higher-risk
nodules was recorded.
Impact of observer variability on test performance
For the seven observers the mean percentage of screening-
positive scans out of all scans was 53% (86/160) with a range
between 44% and 61%. Correspondingly the screening-
negative scan rate was 47% (74/160) with a range between
39% and 56%. Observer pairs differed on average in 12/160
cases (8%) with a range of 1–27 cases between those screen-
ing positive or negative.
According to the NLST database, in 13 cases lung cancer
had been diagnosed in the same year as the CT scan included
in this study. Pooled over all seven observers, the CT scans of
these 13 subjects were classified as Lung-RADS category 4B
in 78% (71/91) and as Lung-RADS 4A in 18% (16/91). The
remaining four classifications referred to the same scan and
included Lung-RADS 3 (n = 2) and Lung-RADS 1/2 (n = 2),
all of them referring to a non-malignant nodule in the same
scan while the actual malignant nodule was not perceived as
the risk-dominant lesion.
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Discussion
The diagnostic and economic success of a lung cancer screen-
ing program will depend on accurate and reproducible
differentiation between high-risk nodules, requiring more in-
tense work-up, and low-risk nodules. Therefore, the ACR de-
veloped the Lung-RADS Assessment Categories to support
radiologists in their decision-making by standardising lung can-
cer screening CT reporting and management recommendations
[4]. The Lung-RADS categories in their current format are
based on visual nodule type classification, manual nodule size
and documentation of growth. For both reading tasks substan-
tial interobserver variability has been reported previously
[9–13]. The goal of our study was therefore to quantify inter-
observer variability for Lung-RADS categorisation of low-dose
screening CTs and to assess its impact on test performance and
subject management. To ensure adequate representation of all
Lung-RADS categories we used an enriched study group that
included baseline and follow-up CTs.
Fig. 1 Two examples of risk-dominant nodules characterised differently
by the seven observers which led to Lung-RADS classification differ-
ences. Each example shows a nodule displayed in magnified view (left
column, field of view of 60 × 60 mm) and normal view (right column).
The three different rows show axial (top), coronal (middle) and sagittal
(bottom) plane. a T1 CT scan with a nodule that was classified as Lung-
RADS 2 by one observer (new small solid nodule), Lung-RADS 4A by
one observer (new part-solid with solid component < 4 mm) and Lung-
RADS 4B by five observers (new part-solid, with solid component > 4
mm). b T1 CT scan with a nodule that was classified as Lung-RADS
category 4A or 4B by five observers (new solid nodule with a measured
diameter ranging from 7 to 9.6 mm) and Lung-RADS category 4B by two
observers (new part-solid nodule with a solid component > 4.0 mm)
Table 2 Factors of disagreement in Lung-RADS category assessment
on observer basis
Cause of observer disagreement Number
Same risk-dominant nodule 250 (26%)
Interpretation: different nodule type 37 (15%)
Interpretation: nodule diameter measurement 207 (83%)
Interpretation: nodule growth 6 (2%)
Different risk-dominant nodule 721 (74%)
Total 971 (100%)
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We found an overall substantial pairwise inter-reader agree-
ment of Lung-RADS categorisation of screening CT scans,
which underlines the value of this categorical system in
harmonising interpretation and management of screening
CTs. Agreement was slightly higher for baseline scans than
for follow-up scans (kappa 0.71 versus 0.63). This finding
might be explained by the fact that for follow-up the complex-
ity of visual assessment including comparison and determina-
tion of nodule growth is higher than for baseline alone.
Variability of Lung-RADS categorisation may refer to
the same risk-dominant nodule or to assignment of differ-
ent nodules as risk-dominant. The first was less common
(26%) and most importantly had only very rarely a substan-
tial impact on subject management (0.4%). The latter was
seen much more frequently (74%) and led to a management
difference (≥ 9 months difference in follow-up time) in 8%
of all reading pairs. Interestingly, not only measurement
and classification differences were responsible for these
discrepancies but apparently also differences in nodule per-
ception given the fact that in the majority of different nod-
ule categorisation the readers selectively annotated their
risk-dominant nodule of choice. We did not ask the ob-
servers to annotate all nodules detected but left it to their
discretion which nodules would be measured. While in the
NLST trial, annotation of all nodules larger than 4 mm was
requested, no recommendation is made in Lung-RADS
concerning this issue. Therefore it remains open to what
extent differences in detection or characterisation
Fig. 2 One example of a risk-
dominant nodule characterised
differently by the observers which
led to Lung-RADS classification
differences with impact on subject
management within one observer
pair. Each example shows a
nodule displayed in magnified
view (left column, field of view of
60 × 60 mm) and normal view
(right column). The three different
rows show axial (top), coronal
(middle) and sagittal (bottom)
plane. This was a benign nodule
detected on a T0 scan and was
classified as Lung-RADS 4A by
one observer (solid nodule with a
measured diameter of 9 mm),
Lung-RADS 3 by five observers
(solid nodule with measured
diameters of 6 or 7 mm) and
Lung-RADS 2 by one observer
(solid nodule with a measured
diameter of 5 mm)
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contributed to the reader variability. Similarly, Pinsky et al.
reported earlier that nodule detection and documentation
substantially varied between screening radiologists in the
NLST trial [18]. Another factor that may have contributed
to disagreement is the small separation between Lung-
RADS categories. For example, the difference between a
Lung-RADS 2 solid nodule and a Lung-RADS 4A solid
nodule is only 2.1 mm (5.4 mm is Lung-RADS 2, 7.5 mm
is Lung-RADS 4A). This Bcloseness^ of the Lung-RADs
categories may also explain why despite relatively frequent
disagreements, only a small proportion had effects on pa-
tient management.
The primary objective of this observer study was to quan-
tify variability of Lung-RADS categorisation without special
focus on actual malignancies. Subjects were randomly includ-
ed in the study group to ensure a balanced distribution of all
Lung-RADS categories, and consequently the number of
scans with malignancies diagnosed in the year of the scan
was limited (n = 13). The actual histology of these malignan-
cies is unknown to us. Nevertheless though the number of
discrepancies with substantial management impact seems
not negligible, it has to be underlined that the number of dis-
crepancies was low in these 13 CTs. With the exceptions of
four readings, the malignant nodules were categorised as
Lung-RADS 4A or 4B, resulting in intensive further diagnos-
tic work-up, and for only two readings the discrepancy result-
ed in a potential delay of more than 9 months.
All observers read 24 cases prior to reading the study
data set in order to become familiar with the Lung-RADS
definitions. They also had a printout of the original Lung-
RADS assessment rules available during their reading.
Nevertheless, wrong assignment of the Lung-RADS catego-
ry criteria occurred in 6% of all readings and in 8.5 cases on
average per observer. Since the main goal of our study was
to investigate inter-reader variability as a result of different
nodule interpretation, we adjusted incorrect Lung-RADS
categories to the observer’s own nodule annotations before
data analysis. However, wrong assignment of the Lung-
RADS category may turn out to be a problem in practice
as well. Computerised tools that automatically assign the
correct Lung-RADS category of a scan once the pertinent
data of one or more nodules have been entered may there-
fore prove useful [19].
Our study has some limitations. Reader experience plays
an important role in observer studies. To capture a realistic
estimation of the extent of observer variability and its impact
on patient management, we included a broad range of ob-
servers with and without experience reading actual screening
CTs. All readers, however, were well trained in thoracic CT
and skilled in interpreting nodules, thus representing radiolo-
gists potentially involved in screening in the future. Parts of
the observer variability, especially with respect to identifica-
tion of the risk-dominant nodule, might still be related to lack
of experience, suggesting that dedicated training is important,
as also articulated by the ACR [20]. Interestingly, no signifi-
cant differences in agreement were observed between resi-
dents and radiologists.
Other limitations are related to the study design. We used
an enriched cohort consisting of 160 cases categorised as
Lung-RADS category 1/2, 3, 4A and 4B on the basis of our
algorithm. We chose this approach to be able to draw mean-
ingful conclusions over the whole spectrum of nodules. This,
however, means that our results need to be interpreted in the
light of the enriched study group and cannot simply be extrap-
olated to an unselected screening cohort.
Secondly, the Lung-RADS category 4X was not consid-
ered in this study. This category gives radiologists the oppor-
tunity to upgrade a Lung-RADS category 3 or 4A nodule to
category 4X on the basis of suspicious morphological findings
and resulting in intensified possibly invasive diagnostic work-
up. In addition to quantitative measures it adds subjective
assessment of nodule morphology which we aimed to exclude
from our analysis.
Thirdly, no reference standard was available for this data
set, since Lung-RADS was not used in the original NLST
annotations. As our study focuses on the effect of interobserv-
er variability and its impact on management no reference stan-
dard was required.
Fourthly, since we did not ask our readers to annotate all
identifiable nodules, we were not able to investigate whether
the assignment of different nodules as risk-dominant was
caused by an error in detection or an error in characterisation.
In future studies, this should be taken into account.
Lastly, we defined a difference in follow-up of at least 9
months as a substantial impact on patient management.
However, whether observer variations would have an impact
on tumour stage and eventually patient outcome remains
open.
In summary, the Lung-RADS Assessment Categories
achieved substantial interobserver agreement. Disagreement
was mainly caused by assigning a different risk-dominant
nodule. In our enriched cohort disagreement led to different
follow-up interval of more than 9 months in 8% of all reading
pairs with little effect on the diagnosis of the malignancies
within this series. The use of (semi-)automatic detection, seg-
mentation and classification tools would likely reduce dis-
agreement amongst readers, but the availability of these tools
in clinical practice is still low and they require careful
standardisation.
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